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1. Introduction
  PEGylation, generally described as the molecular 
attachment of polyethylene glycols (PEGs) with different 
molecular weights to active drug molecules or surface 
treatment of drug-bearing particles with PEGs, is one of 
the most promising and extensively studied strategies 
with the goal of improving the pharmacokinetic behavior 
of the therapeutic drugs[1]. A variety of PEGs, both linear 
and branched, with different molecular weights have 
been exploited successfully for use in this procedure in 
the form of reactive PEG species. Both reversible and 
irreversible PEG-drug conjugates have been prepared 
with relative advantages/disadvantages. The main 
pharmacokinetic outcomes of PEGylation are summarized 
as changes occurring in overall circulation life-span, tissue 
distribution pattern, and elimination pathway of the parent 
drug/particle[2]. Based on these favorable pharmacokinetic 
consequences leading to desired pharmacodynamic 
outcomes, a variety of proteins/peptides as well as small 
molecule drugs have been PEGylated and evaluated 
successfully. Also a number of corresponding products have 
been approved by the Food Drug Adminisctration (FDA) for 
specific clinical indications and some others are underway.    
  Many biopharmaceuticals suffer from performance 
problems due to short half lives, immunogenicity, and poor 
solubility and stability[3]. Clinically proven PEGylation 
Technology can improve performance and dosing 
convenience of peptides, proteins, some water soluble drugs, 
antibodies, oligonucleotides and many small molecules by 
optimizing pharmacokinetics, increasing bioavailability, 
and decreasing immunogenicity and dosing frequency. 
Nektar Advanced PEGylation Technology also can increase 
therapeutic efficacy by increasing drug concentration, 
improving biodistribution, and prolonging dwell time at the 
site of action[4]. As a result, therapeutic drug concentrations 
can be achieved with less frequent dosing and significant 
benefit to patients with injection and long time medication 
especially diabetes management treatment[5]. Hence, this 
study was aimed at investigating the mixing characteristics 
of PEGylated-mucin by differential scanning calorimeter 
(DSC). 
2. Materials and methods 
2.1. Materials and reagent
  PEG Mw-2000, snail, acetone, DSC machine. All other 
chemical are of analytical grade. Distilled water were 
freshly prepared and used for the study.
2.2. Extraction of snail mucin (slime)
  After procurement, the shells of the giant African land 
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snails were knocked open at the apex and a spirally coiled 
rod was inserted to remove the fleshy body from where the 
excretory parts were removed. The fleshy parts were then 
placed in 250 mL of water and washed several times until the 
(slime) mucin was completely washed off. These washings 
were pooled together in a plastic bucket, precipitated 
with chilled acetone and lyophilized in a lyophilizer. The 
greyish-brown lyophilized flakes of the snail mucin were 
pulverized into fine powder using a mortar and pestle and 
stored in an airtight container until used.  
2.3. Preparation of PEGylated-mucin
  Mucin and PEG were mixed in the following ratios: 1÷1, 
0÷1 , 2÷1, 1÷3 , 3÷1 to form batch (A-E). A known 
quantity of mucin and polyethylene glycol were weighed and 
put in a separate 100 mL baker. A total of 20 mL of solvent 
(water) were added into each beaker and were  allowed to 
hydrate for 72 h. The solution were later mixed together 
and allowed to stand for another 72 h, this was to give room 
for possible interactions and bond formation. The mixture 
was precipitated with chilled acetone. The precipitate was 
collected, dried, pulverized and kept in a tight container 
until used. This method was applied to all the batches.
2.4. Solubility profile of snail mucin
  The solubility of snail mucin in several solvents was 
determined by dispersing 100 mg of the snail mucin in 
definite volume of each solvent- acetone, ethanol, water, 
sodium hydroxide, hydrochloric acid and ammonium 
hydroxide at different temperatures (27 曟,  35 曟, 40 曟).
2.5. Physiochemical properties of snail mucin
  The physiochemical properties of the mucin were carried 
out using the standard analytical method as described in our 
previous work[6].
2.6. DSC study
  In order to characterize the thermal behavior of the 
polymer, DSC was performed by using a DSC821e (Mettler 
Toledo, Greifensee, Switzerland) equipped with a 
refrigerated cooling system (RCS). The system was cali 
brated by an indium standard. Approximately 5 mg of 
PEGylated mucin or polymer was weighed in aluminum pans 
and sealed. The calibration pan was the hermetically sealed 
type, and heating (tempearture rise) was 5 degrees per min 
from 20 to 220 degrees and then cooled back to 20 i.e. two 
way process. The results were expressed as the mean of two 
independent measures.
3. Results 
  The physicochemical test showed copiously present of 
carbohydrate, rich of protein and trace amount of fat.
  The solubility test on the mucin at various temperature 
showed that at 30 曟 and 35 曟, the mucin powder were 
soluble, and more at 35 曟. In acetone, ethanol, 0.1 M 
NaOH, 0.1M H2SO4 and 0.1 NH4OH, it was not soluble at the 
temperature tested. Besides, Figures 1-5 showed the results 
of the thermographs of the various formulation and peaks, 
transitions temperature and crystallization state. Double 
peaks (exothermic and endothermic) were very obvious in 
the formulations that contained mucin-PEG as compare to 
sample B with only one peak that served as  a control as it 
contained only mucin without PEG. This indicated the basic 
variation and the role of PEG in the preparation. 
 
Figure 1.  Sample A thermogragh.
 
Figure 2.  Sample B thermogragh.
 
 Figure 3.  Sample C thermogragh.
 
Figure 4.  Sample D thermogragh.
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   Figure 5.  Sample E thermogragh.
 
4. Discussion
  Results of some physiochemical tests performed on the 
snail mucin showed that carbohydrates, proteins and trace 
amounts of fats. In both wet and dry states, the extracted 
mucin was light-brownish in colour, tasteless with a 
pleasant meaty odour. Snail mucin when dispersed in water 
gave a slight viscous dispersion. This is unlike gelatin - a 
typical purified animal protein that swells in cold water with 
a resultant colloidal solution when heated. The snail mucin 
is not soluble in ethanol, acetone, 0.1 M sodium hydroxide, 
ammonium hydroxide and sulphuric acid. Research have 
shown that snail mucin contained both soluble and insoluble 
fraction, the soluble fraction gave the brownish colour as 
observed in this study[7]. 
  The various formulations show that there are different 
peak formations and the melting point was also different. 
The DSC was used to detect evidence of good PEGylation 
and molecular bond interaction between mucin and 
poly(ethylene glycol-2000) for possible drug delivery. The 
DSC curves show an initial characteristics endothermic peak 
which represent a melting point of the polymer, and show 
a closed temperature to the glass transition temperature of 
A-E respectively. The initial endothermic curve in all the 
batches with exception of mucin alone (sample B) were very 
sharp with narrow width. The Tm range from 58.58 曟 to  61.17 曟 
only sample B gave high temperature value of 149.75曟, this is an 
indication that there are sign of impurity or the substance 
is partially crystallised as shown in the size of width of 
the peak. The crystallization temperature Tc ranged from 
37.08 曟 to 39.86 曟 in all the sample. And the variation 
were not significant at P>0.05. The mucin (sample B) alone 
shows a double peaks. All samples, except sample B, show 
a very good exothermic sharp peak curve which represents 
the crystallization phase. It indicates a transitional change 
in the phase of the polymer. The curve in all the polymer 
matrices showed that both the PEG and mucin have an 
interaction, although weakly in nature because of some of 
the batches that show a small second peak as in sample B. 
This further suggests that the hydrogen-bonding interactions 
are responsible for the binding during PEGylation as shown 
in peak A, C, D and E. The weaker mucin interaction in the 
PEGylation exercise, however, allow for PEG coated surface 
to adhere to surface-bound mucin in the presence of soluble 
mucin when they are combined. Such characteristics are 
particularly desirable for oral drugs delivery carriers[7].
 In all the batches evaluated using DSC curve, glass 
transition temperature ranges from 126.85 曟 to 38.39 曟 
except mucin with a low Tg of 111 曟. It gave an indication 
that there was possible bond formation between the mucin 
and the PEG (Mw 2000) which would automatically give birth 
to new polymer. Studies show that there is obvious hydrogen 
bond interaction between the mucin  and the PEG-2000[8]. 
Researchers have shown that PEGylation has the potential 
to increase treatment distances to more than a centimetre, 
which may be sufficient to prevent the recurrence of human 
brain tumours. Since polyethylene glycol is known for its 
biocompatibility and its ability to solubilise hydrophobic 
molecules in water, it is believed that PEG-drug conjugates 
show great potential for improving the brain distribution of 
drug released from controlled-release polymers[9].
  In a related study PEGylation has already been used to 
improve the delivery of interferons in the treatment of 
hepatitis and drugs to support blood function in patients 
undergoing cancer chemotherapy, and is being evaluated 
for use with a number of experimental therapies[10].  The 
comparative high Tg obtained for mucin as compared with 
mucin-PEG is an indication of new polymer formation. 
Mucin is a glycoprotein made up of N-glycosidic linkages 
of peptide chains and also a carbohydrate moiety. The 
functional groups of amino acid back bone of the peptide 
chain may bind to a large functional group of the PEG via 
some weak forces of interaction like hydrogen and van der 
Waal forces to create a large polymer PEGylation with less 
flexible structure.  The high chain rigidity thus requires 
a high temperature to cause the second order transitional 
change in the polymer thus resulting in high transition 
temperature. The second endothermic peak is a melting 
peak with characteristic onset approximately equal to that of 
mucin. This result can serve as a basis for further evaluation 
of the PEGylation method and use as drug delivery. The 
finding in this study can serve as a building block for further 
evaluation of the PEGylation technology and it possible use 
in the pharmaceutical industries for target site drug delivery.
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